Page last updated: 2024-10-24

chelerythrine and Amyotrophic Lateral Sclerosis

chelerythrine has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oberstadt, M1
Stieler, J1
Simpong, DL1
Römuß, U1
Urban, N1
Schaefer, M1
Arendt, T1
Holzer, M1

Other Studies

1 other study available for chelerythrine and Amyotrophic Lateral Sclerosis

ArticleYear
TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole.
    Scientific reports, 2018, 02-02, Volume: 8, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Auranofin; Benzophenanthridines; Cell Line, Tumor; DNA-Bindi

2018